Shay Capital »

Lexeo Therapeutics shares owned by Shay Capital

Quarter-by-quarter ownership of Lexeo Therapeutics (LXEO) shares owned by Shay Capital from 13F filings

Historical chart of Shay Capital investment in Lexeo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lexeo Therapeutics held by Shay Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexeo Therapeutics by Shay Capital

Quarter filed Position value Share count Share price at filing
2025-03-31 $150k 43k 3.47

More positions owned by Shay Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Purecycle Technologies (PCT)
Ishares Silver Tr Ishares (SLV)
Ftai Aviation SHS (FTAI)
Vor Biopharma Com New Call Option
Sable Offshore Corp Com Shs (SOC)
First Solar (FSLR)
Tesla Motors (TSLA)
Warner Bros Discovery Com Ser A (WBD)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Alibaba Group Hldg Sponsored Ads (BABA)
Agnc Invt Corp Com reit (AGNC)
Jd.com Spon Ads Cl A (JD)
A2z Cust2mate Solutions Corp (AZ)

View all positions for Shay Capital

Top funds holding Lexeo Therapeutics

Henderson Group
Frazier Life Sciences Management
Balyasny Asset Management
Affinity Asset Advisors
Citadel Advisors
Vestal Point Capital
Woodline Partners
Millennium Management
Vanguard Group
BlackRock
Point72 Asset Management
ADAR1 Capital Management
Blackstone Group
D1 Capital Partners
683 Capital Management

View all funds holding Lexeo Therapeutics